Beijing Health (Holdings) Limited (HKG:2389)
Hong Kong · Delayed Price · Currency is HKD 0.0810
+0.0010 (1.25%)
Sep 2, 2026, 2:07 PM HKT
Beijing Health (Holdings) Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 110.89 | 157.2 | 149.95 | 140.35 | 166.48 | 203.78 | |
Revenue Growth | -27.63% | 4.84% | 6.84% | -15.70% | -18.30% | 35.95% |
Cost of Revenue | 85.04 | 114.75 | 114.27 | 101.87 | 119.97 | 165.21 |
Gross Profit | 25.85 | 42.45 | 35.68 | 38.47 | 46.51 | 38.57 |
Selling, General & Admin | 93.58 | 95.15 | 95.05 | 103.38 | 111.96 | 116.03 |
Operating Expenses | 94.89 | 96.45 | 95.47 | 104.38 | 115.7 | 114.68 |
Operating Income | -69.04 | -54 | -59.79 | -65.9 | -69.19 | -76.12 |
Interest Expense | -6.78 | -2.52 | -0.23 | -0.38 | -1.44 | -2.07 |
Interest & Investment Income | 21.62 | 21.62 | 12.49 | 23.11 | 27.5 | 36.62 |
Earnings From Equity Investments | -8.39 | -15.88 | -30.43 | -23.02 | -43.5 | -17.89 |
Currency Exchange Gain (Loss) | 3.1 | 3.1 | -29.29 | 9.24 | - | 4.03 |
Other Non Operating Income (Expenses) | -31.68 | -31.27 | 12.23 | 1.53 | -11.22 | 0.52 |
EBT Excluding Unusual Items | -91.17 | -78.95 | -95.03 | -55.42 | -97.84 | -54.89 |
Gain (Loss) on Sale of Investments | 11.43 | 11.43 | -10.45 | 1.48 | -0.64 | 19.11 |
Gain (Loss) on Sale of Assets | -14.98 | -14.98 | -0.05 | -0.07 | 0.66 | - |
Asset Writedown | -21.73 | -19.97 | -13.89 | -12.15 | -4.88 | -2.41 |
Other Unusual Items | - | - | - | -2.61 | - | -8.43 |
Pretax Income | -116.46 | -102.47 | -119.42 | -68.78 | -102.7 | -46.62 |
Income Tax Expense | -2.33 | -0.48 | -3.85 | -7.06 | -3.89 | -6.39 |
Earnings From Continuing Operations | -114.13 | -102 | -115.58 | -61.72 | -98.81 | -40.23 |
Net Income to Company | -114.13 | -102 | -115.58 | -61.72 | -98.81 | -40.23 |
Minority Interest in Earnings | 10.66 | 1.09 | -0.64 | -0.16 | 1.11 | 0.82 |
Net Income | -103.47 | -100.91 | -116.22 | -61.88 | -97.7 | -39.41 |
Net Income to Common | -103.47 | -100.91 | -116.22 | -61.88 | -97.7 | -39.41 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6,071 | 6,059 | 6,059 | 6,059 | 6,070 | 6,079 |
Shares Outstanding (Diluted) | 6,071 | 6,059 | 6,059 | 6,059 | 6,070 | 6,079 |
Shares Change | 0.20% | - | - | -0.18% | -0.15% | - |
EPS (Basic) | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 |
EPS (Diluted) | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -33.97 | -42.2 | -45.1 | -34.4 | -22.81 |
Free Cash Flow Per Share | - | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
Gross Margin | 23.31% | 27.01% | 23.79% | 27.41% | 27.94% | 18.93% |
Operating Margin | -62.26% | -34.35% | -39.88% | -46.96% | -41.56% | -37.35% |
Profit Margin | -93.31% | -64.19% | -77.51% | -44.09% | -58.68% | -19.34% |
Free Cash Flow Margin | - | -21.61% | -28.15% | -32.13% | -20.66% | -11.19% |
EBITDA | -64.54 | -49.76 | -55.86 | -61.34 | -64.03 | -65.77 |
EBITDA Margin | -58.20% | -31.65% | -37.25% | -43.71% | -38.46% | -32.28% |
D&A For EBITDA | 4.5 | 4.25 | 3.94 | 4.56 | 5.15 | 10.35 |
EBIT | -69.04 | -54 | -59.79 | -65.9 | -69.19 | -76.12 |
EBIT Margin | -62.26% | -34.35% | -39.88% | -46.96% | -41.56% | -37.35% |
Advertising Expenses | - | 4.09 | 3.74 | 2.75 | 2.24 | 1.72 |